Indications for allogeneic stem cell transplantation in patients with AML

被引：0
|
作者：
Passweg, J. [1 ]
机构：
[1] Univ Spital Basel, Hamatol, Basel, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V747
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] Outcome prediction by the knowledge bank approach in AML patients undergoing allogeneic stem cell transplantation
    Herrmann, L.
    Bischof, L.
    Backhaus, D.
    Brauer, D.
    Franke, G. -N.
    Vucinic, V.
    Platzbecker, U.
    Jentzsch, M.
    Schwind, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 108 - 108
  • [32] The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients
    Chen, Wen-Chun
    Gau, Jyh-Pyng, Sr.
    Hsiao, Liang-Tsai
    Liu, Chia-Jen
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Liu, Jin-Hwang
    Chiou, Tzeon-Jye
    BLOOD, 2019, 134
  • [33] Indications for allogeneic stem cell transplantation 2017: acute myeloid leukemia
    Roellig, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 116 - +
  • [34] Current indications for reduced-intensity allogeneic stem cell transplantation
    Haddad, N
    Rowe, JM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (03) : 377 - 386
  • [35] Diagnostic Tools in the Indications for Allogeneic Stem Cell Transplantation in Myelodysplastic Syndromes
    Bacher, Ulrike
    Haferlach, Claudia
    Kroeger, Nicolaus
    Schnittger, Susanne
    Kern, Wolfgang
    Wiedemann, Bettina
    Zander, Axel Rolf
    Haferlach, Torsten
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 1 - 11
  • [36] Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML
    Impola, Ulla
    Larjo, Antti
    Salmenniemi, Urpu
    Putkonen, Mervi
    Itala-Remes, Maija
    Partanen, Jukka
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [37] Allogeneic stem cell transplantation in elderly patients
    Shapira, M. Y.
    Resnick, I. B.
    Grisariu, S.
    Samuel, S.
    Dray, L.
    Or, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S301 - S301
  • [38] THE OUTCOME OF SECONDARY AML PATIENTS WITH PRIOR BREAST CANCER UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION IS AS GOOD AS DE NOVO AML
    Aydogan, Merve
    Karakaya, Bulent
    Ermis, Gul Yavuz
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Yuksel, Meltem Kurt
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 181 - 182
  • [39] Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
    Greiner, Jochen
    Goetz, Marlies
    Bunjes, Donald
    Hofmann, Susanne
    Wais, Verena
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [40] Optimization of fludarabine-pharmacokincetics to reduce the RI in AML patients after allogeneic stem cell transplantation
    Thavayogarajah, T.
    Nair, G.
    Mueller, D.
    Schanz, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 151 - 151
12345